Entrectinib in children and young adults with solid or primary CNS tumors harboring <i>NTRK</i>, <i>ROS1</i>, or <i>ALK</i> aberrations (STARTRK-NG)
Ami V. Desai(University of Chicago Medical Center), Elizabeth Fox(Children's National), Ellen M. Basu(Memorial Sloan Kettering Cancer Center), Luke Maese(University of Utah), Amy E. Armstrong(Washington University in St. Louis), Amit J. Sabnis(University of California, San Francisco), Amar Gajjar(St. Jude Children's Research Hospital), Brian Weiss(Cincinnati Children's Hospital Medical Center), Janet Yoon(University of California San Diego), Karen Gauvain(Washington University in St. Louis), Mufiza Farid‐Kapadia(Roche (Canada)), Nicholas Whipple(University of Utah), Giles Robinson(St. Jude Children's Research Hospital), Clare Devlin(Roche (United Kingdom)), Alison K. Cardenas, Margaret E. Macy(Children's Hospital Colorado), Jennifer H. Foster(Children's Cancer Center), Thomas F. Cash(University of Liverpool), Suzanne Shusterman(Dana-Farber Cancer Institute), Christine A. Pratilas(Johns Hopkins University), Guillaume Bergthold(Roche (Switzerland)), Georgina Meneses‐Lorente(Roche (United Kingdom)), Saibah Chohan(Roche (Canada)), Lynley V. Marshall(Royal Marsden Hospital), Hubert Caron(Roche (Switzerland)), Mohamed S Abdelbaki(Nationwide Children's Hospital), Nadège Corradini(Institut d’Hématologie et d’Oncologie Pédiatrique), Katherine E. Hutchinson(Vanderbilt University), Edna Chow Maneval(Dana (United States))
Cited by 136
Related Papers
BRAF mutation predicts sensitivity to MEK inhibition
|Nature|2005|1.3k
Novel mutations target distinct subgroups of medulloblastoma
|Nature|2012|853
Integrated Molecular Genetic Profiling of Pediatric High-Grade Gliomas Reveals Key Differences With the Adult Disease
|Journal of Clinical Oncology|2010|657
Risk stratification of childhood medulloblastoma in the molecular era: the current consensus
|Acta Neuropathologica|2016|650
Optimization of Dosing for EGFR-Mutant Non–Small Cell Lung Cancer with Evolutionary Cancer Modeling
|Science Translational Medicine|2011|530